Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 9, 2013, Pages

  Sheng, Liang ^a   Jiang, Bijie ^a   Rui, Liangyou ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gluconeogenesis; Hepatocytes; Lipogenesis; NAFLD; Obesity

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; INTRINSIC FACTOR; LIPID; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL LEVEL; CELL POPULATION; CELL VIABILITY; CYTOKINE RESPONSE; FAT INTAKE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCONEOGENESIS; HEPATITIS; INTRACELLULAR LIPID CONTENT; LIPOGENESIS; LIVER CELL; LIVER CELL DAMAGE; LIVER METABOLISM; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

GLUCONEOGENESIS; HEPATOCYTES; LIPOGENESIS; NAFLD; OBESITY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL SEPARATION; CELL SURVIVAL; COLORING AGENTS; CULTURE MEDIA, CONDITIONED; DIETARY FATS; FATTY ACIDS; GLUCOSE; HEPATOCYTES; IN SITU NICK-END LABELING; INFLAMMATION; LIPID METABOLISM; LIPOGENESIS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; REAL-TIME POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TRIGLYCERIDES;

EID: 84887005701     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00401.2013     Document Type: Article

References (28)

1. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212-223, 2009.
2. Braeuning A, Ittrich C, Kohle C, Hailfinger S, Bonin M, Buchmann A, Schwarz M. Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J 273: 5051-5061, 2006.
3. Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol 59: 583-594, 2013.
4. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 332: 1519-1523, 2011.
5. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54: 133-144, 2011.
6. Diehl AM. Hepatic complications of obesity. Gastroenterol Clin North Am 39: 57-68, 2010.
7. Gebhardt R, Mecke D. Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J 2: 567-570, 1983.
8. Goncalves LA, Vigario AM, Penha-Goncalves C. Improved isolation of murine hepatocytes for in vitro malaria liver stage studies. Malaria J 6: 169, 2007.
9. Hijmans BS, Grefhorst A, Oosterveer MH, Groen AK. Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences. Biochimie 2013 Jun 20. doi:pii: S0300-9084(13)00173-9. 10.1016/j.biochi.2013.06.007. [Epub ahead of print].
10. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
11. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284: E671-E678, 2003.
12. Kennedy DJ, Kashyap SR. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. Metab Syndrome Relat Dis 9: 239-245, 2011.
13. Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 23: 1635-1648, 2008.
14. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55: 560-578, 2010.
15. Micuda S, Fuksa L, Brcakova E, Osterreicher J, Cermanova J, Cibicek N, Mokry J, Staud F, Martinkova J. Zonation of multidrug resistance-associated protein 2 in rat liver after induction with dexamethasone. J Gastroenterol Hepatol 23: e225-e230, 2008.
16. Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, Seya T, Takaku H, Shimotohno K. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J Virol 87: 8169-8178, 2013.
17. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30: 398-408, 2004.
18. Quistorff B, Katz N, Witters LA. Hepatocyte heterogeneity in the metabolism of fatty acids: discrepancies on zonation of acetyl-CoA carboxylase. Enzyme 46: 59-71, 1992.
19. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-G858, 2006.
20. Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, Blaner WS, Goldberg IJ, Schwabe RF, Chua SC Jr, Huang LS. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem 283: 13087-13099, 2008.
21. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118: 2992-3002, 2008.
22. Sheng L, Cho KW, Zhou Y, Shen H, Rui L. Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid beta-oxidation. J Biol Chem 286: 38128-38135, 2011.
23. Sheng L, Zhou Y, Chen Z, Ren D, Cho KW, Jiang L, Shen H, Sasaki Y, Rui L. NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 18: 943-949, 2012.
24. Smith DD Jr, Campbell JW. Distribution of glutamine synthetase and carbamoyl-phosphate synthetase I in vertebrate liver. Proc Natl Acad Sci USA 85: 160-164, 1988.
25. Turpin SM, Hoy AJ, Brown RD, Rudaz CG, Honeyman J, Matzaris M, Watt MJ. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 54: 146-156, 2011.
26. Wang J, Olin M, Rozell B, Bjorkhem I, Einarsson C, Eggertsen G, Gafvels M. Differential hepatocellular zonation pattern of cholesterol 7alpha-hydroxylase (Cyp7a1) and sterol 12alpha-hydroxylase (Cyp8b1) in the mouse. Histochem Cell Biol 127: 253-261, 2007.
27. Wu JW, Wang SP, Alvarez F, Casavant S, Gauthier N, Abed L, Soni KG, Yang G, Mitchell GA. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 54: 122-132, 2011.
28. Zhou Y, Jiang L, Rui L. Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem 284: 11152-11159, 2009.